CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes CEO gave up 41,687 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes CEO gave up 58,054 shares (to pay taxes)
- 8-K Event Results of operations · Other events
- 4 Grant or award CFO acquired 400,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Derivatives Options or other derivatives
Page 6 of 19 · 362 filings